Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human autologous bone-forming cells derived from bone marrow stem cells

EU orphan designation number: EU/3/07/490   
Active ingredient: Human autologous bone-forming cells derived from bone marrow stem cells
Indication: Treatment of non-traumatic osteonecrosis
Sponsor: Bone Therapeutics SA
8 rue Adrienne Bolland, B-6041 Gosselies, Belgique

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2007 Centralised Orphan - Designation EMEA/OD/052/07 (2007)5371 of 29/10/2007